Non-Crossover Study of the LMA Protector Versus Ambu AuraGain
- Conditions
- Airway Morbidity
- Interventions
- Procedure: function testsDevice: LMA ProtectorTMDevice: Ambu AuraGainTM
- Registration Number
- NCT02820792
- Lead Sponsor
- Schulthess Klinik
- Brief Summary
The LMA ProtectorTM is a new extraglottic airway device which brings together features of both the LMA ProSealTM (high seal cuff, gastric access and bite block - to facilitate ventilation, airway protection and airway obstruction, respectively) and the LMA UniqueTM (single use - prevention of disease transmission). In the following randomized study the investigators test the hypothesis that ease of insertion, oropharyngeal leak pressure, fiberoptic position and ease of gastric tube placement differ between the LMA ProtectorTM and the Ambu AuraGainTM in paralyzed, anesthetized patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 96
- ASA 1 or 2
- Age 19-65 yr
- Written informed consent
- Difficult airway
- Non fasted
- BMI > 35
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Ambu AuraGainTM function tests function tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion LMA ProtectorTM LMA ProtectorTM function tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion Ambu AuraGainTM Ambu AuraGainTM function tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion LMA ProtectorTM function tests function tests: ease of insertion, oropharyngeal seal pressure, fiberoptic position, ease of ventilation, occult blood, gastric tube insertion
- Primary Outcome Measures
Name Time Method oropharyngeal leak pressure 5 min Oropharyngeal leak pressure was determined by closing the expiratory valve of the anesthesia breathing system and a fixed gas flow of 3 l minute-1. The airway pressure at which an equilibrium was reached was noted (maximum allowed 40 cm H2O).
- Secondary Outcome Measures
Name Time Method anatomic position 5 min The anatomic position was assessed by passing a fiberoptic scope through the airway tube stopping 0,5 cm prior to the end of the tube. The airway tube view was scored using an established scoring system.
Trial Locations
- Locations (2)
Christian Keller MD, M.Sc.
🇨ðŸ‡Zürich, Switzerland
Schulthess Klinik
🇨ðŸ‡Zürich, Switzerland